The therapeutic effect of death: Newcastle disease virus and its antitumor potential

Sara Cuadrado-Castano1, Maria T Sanchez-Aparicio1, Adolfo García-Sastre2

  • 1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Virus Research
|July 30, 2015
PubMed

Insights

Programmed cell death, including necroptosis and pyroptosis, is crucial for multicellular life. Newcastle disease virus (NDV) research reveals how manipulating host cell death pathways can enhance its cancer-fighting potential.

Area of Science:

  • Cell Biology
  • Virology
  • Immunology

Background:

  • Programmed cell death (PCD) encompasses diverse mechanisms beyond apoptosis, including necroptosis, pyroptosis, and autophagic cell death.
  • Viruses exploit host PCD pathways, while host cells activate defense mechanisms, including self-destruction, to combat infection.
  • Altered PCD contributes to diseases like cancer, and understanding PCD is vital for developing novel therapies.

Purpose of the Study:

  • To review the multimodal cell death responses induced by Newcastle disease virus (NDV).
  • To explore how manipulating host PCD can enhance the antitumor capacity of NDV as an oncolytic therapy.

Main Methods:

  • Literature review focusing on programmed cell death mechanisms.
  • Analysis of viral-host interactions in the context of cell death.
  • Examination of Newcastle disease virus (NDV) as an oncolytic agent.

Main Results:

  • NDV induces a multimodal programmed cell death response in infected cells.
  • Viral manipulation of host cell death pathways is a key aspect of NDV infection.
  • The interplay between NDV and host PCD influences therapeutic outcomes.

Conclusions:

  • Programmed cell death is a complex host defense mechanism manipulated by viruses.
  • Newcastle disease virus (NDV) shows promise as an oncolytic therapy by engaging multimodal cell death pathways.
  • Targeting host cell death pathways could enhance the efficacy of NDV-based cancer treatments.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K